Making Strides Against Kidney Cancer

Join with the AACR to find better ways to prevent and treat kidney cancer.

Kidney cancer is among the most common cancers in the United States, with over 65,000 new diagnoses and nearly 15,000 deaths in 2018, according to federal estimates.

Also known as renal cancer, kidney cancer is often treated with surgery to remove all or part of the affected organ. Some patients may be given chemotherapy or radiation therapy after surgery to destroy unseen cancer cells that may remain following the procedure. For a few patients, most commonly those with advanced disease, treatment may include a molecularly targeted therapeutic or an immunotherapeutic.

Smoking is a risk factor for kidney cancer, as is misuse of certain pain medicines, including over-the-counter drugs. In addition, certain genetic conditions, such as von Hippel-Lindau disease, increase a person’s risk of developing kidney cancer.

March is Kidney Cancer Awareness Month.

What Is the AACR Doing in This Area?

Gifts made in memory of Dr. Richard L. Welsh were graciously donated to support a young investigator presenting a high-quality abstract in renal cancer at the AACR Annual Meeting. The 2018 AACR Scholar-in-Training Award in Memory of Dr. Richard L. Welsh went to Khalid Saeed, MS, of the University of Helsinki, for his abstract, “Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine.”

Last year the AACR provided over $64 million in grants and awards funding lifesaving cancer research. There are many ways you can support our mission to prevent and cure all cancers. Take Action

The American Association for Cancer Research (AACR) is a 501c3 registered nonprofit organization with offices at 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106 | 215.440.9300